1
Janssen-Heijnen, M.L.G., van Steenbergen, L.N., Voogd, A.C., Tjan-Heijnen, V.C.G., Nijhuis, P.H., Poortmans, P.M., Coebergh, J.W.W., van Spronsen, D.J.
Veröffentlicht in: Janssen-Heijnen , M L G , van Steenbergen , L N , Voogd , A C , Tjan-Heijnen , V C G , Nijhuis , P H , Poortmans , P M , Coebergh , J W W & van Spronsen , D J 2014 , ' Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands ' , Annals of Oncology , vol. 25 , no. 1 , pp. 64-68 . https://doi.org/10.1093/annonc/mdt424;
2014
Veröffentlicht in: Janssen-Heijnen , M L G , van Steenbergen , L N , Voogd , A C , Tjan-Heijnen , V C G , Nijhuis , P H , Poortmans , P M , Coebergh , J W W & van Spronsen , D J 2014 , ' Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands ' , Annals of Oncology , vol. 25 , no. 1 , pp. 64-68 . https://doi.org/10.1093/annonc/mdt424;
2014
2
Meegdes, M., Geurts, S.M.E., Erdkamp, F.L.G., Dercksen, M.W., Vriens, B.E.P.J., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.M.H., Teeuwen, N.J.A., Boer, M., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022
Veröffentlicht in: Meegdes , M , Geurts , S M E , Erdkamp , F L G , Dercksen , M W , Vriens , B E P J , Aaldering , K N A , Pepels , M J A E , Winkel , L M H , Teeuwen , N J A , Boer , M & Tjan-Heijnen , V C G 2022 , ' The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2-advanced breast cancer patients: A study of the Dutch SONABRE Registry ' , International Journal of Cancer , vol. 150 , no. 1 , pp. 124-131 . https://doi.org/10.1002/ijc.33785;
2022
3
Seferina, S.C., Lobbezoo, D.J.A., de Boer, M., Dercksen, M.W., van den Berkmortel, F., van Kampen, R.J.W., van de Wouw, A.J., de Vries, B., Joore, M.A., Peer, P.G.M., Voogd, A.C., Tjan-Heijnen, V.C.G.
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015
Veröffentlicht in: Seferina , S C , Lobbezoo , D J A , de Boer , M , Dercksen , M W , van den Berkmortel , F , van Kampen , R J W , van de Wouw , A J , de Vries , B , Joore , M A , Peer , P G M , Voogd , A C & Tjan-Heijnen , V C G 2015 , ' Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium ' , Oncologist , vol. 20 , no. 8 , pp. 856-863 . https://doi.org/10.1634/theoncologist.2015-0006;
2015
4
5
6
van Roozendaal, L. M., Vane, M. L. G., van Dalen, T., van der Hage, J. A., Strobbe, L. J. A., Boersma, L. J., Linn, S. C., Lobbes, M. B. I., Poortmans, P. M. P., Tjan-Heijnen, V. C. G., Van de Vijver, K. K. B. T., de Vries, J., Westenberg, A. H., Kessels, A. G. H., de Wilt, J. H. W., Smidt, M. L.
Veröffentlicht in: van Roozendaal , L M , Vane , M L G , van Dalen , T , van der Hage , J A , Strobbe , L J A , Boersma , L J , Linn , S C , Lobbes , M B I , Poortmans , P M P , Tjan-Heijnen , V C G , Van de Vijver , K K B T , de Vries , J , Westenberg , A H , Kessels , A G H , de Wilt , J H W & Smidt , M L 2017 , ' Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up : a Dutch randomized controlled multicentre trial (BOOG 2013-08) ' , BMC Cancer , vol. 17 , 459 . https://doi.org/10.1186/s12885-017-3443-x;
2017
Veröffentlicht in: van Roozendaal , L M , Vane , M L G , van Dalen , T , van der Hage , J A , Strobbe , L J A , Boersma , L J , Linn , S C , Lobbes , M B I , Poortmans , P M P , Tjan-Heijnen , V C G , Van de Vijver , K K B T , de Vries , J , Westenberg , A H , Kessels , A G H , de Wilt , J H W & Smidt , M L 2017 , ' Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up : a Dutch randomized controlled multicentre trial (BOOG 2013-08) ' , BMC Cancer , vol. 17 , 459 . https://doi.org/10.1186/s12885-017-3443-x;
2017